Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 30, Issue 2, 2011, Pages 123-137

  Hamsa, T P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

B16F 10 melanoma cells; Harmine; Invasion; Matrix metalloproteinases; Metastasis; Proliferation

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HARMINE; HEXOSAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; URONIC ACID; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFECT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION; IN VITRO STUDY; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SURVIVAL RATE;

MURINAE; MUS; PEGANUM HARMALA;

EID: 79960036384     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v30.i2.40     Document Type: Article

References (63)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66.
2. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
3. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
4. Cavallaro U, Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta. 2001 Nov 30;1552(1):39-45.
5. Pasco S, Brassart B, Ramont L, Maquart FX, Monboisse JC. Control of melanoma cell invasion by type IV collagen. Cancer Detect Prev. 2005;29(3):260-6.
6. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol. 1998 Aug;2(4):466-71.
7. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001;7(1):14-23.
8. Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells. 2010 Feb;29(2):209-15.
9. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990 Oct 1;50(19):6184-91.
10. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/ type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci. 1993 Apr;104(Pt 4):991-9.
11. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002 Mar 28;21(14):2245-52.
12. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010;112(1):3-25.
13. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci. 2005 Jun;96(6):317-22.
14. Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu YH, Sung JS, et al. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci. 2008 May;99(5):905-13.
15. Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol. 2006 Dec;80(6):1197-213.
16. Lee SJ, Chung IM, Kim MY, Park KD, Park WH, Moon HI. Inhibition of lung metastasis in mice by oligonol. Phytother Res. 2009 Jul;23(7):1043-6.
17. Torii Y, Susumu S, Obara T. A case of lung cancer showing a bronchial cast shadow caused by impaction of the squamous cell carcinoma itself [Article in Japanese]. Nihon Kokyuki Gakkai Zasshi. 2006 Nov;44(11):844-7.
18. Pan MR, Chang HC, Hung WC. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal. 2008 Jun;20(6):1134-41.
19. Yang XC, Tu CX, Luo PH, Zhu H, Zhu DF, Wu HH, et al. Antimetastatic activity of MONCPT in preclinical melanoma mice model. Invest New Drugs. 2010 Dec;28(6):800-11.
20. Palmieri D, Horak CE, Lee JH, Halverson DO, Steeg PS. Translational approaches using metastasis suppressor genes. J Bioenerg Biomembr. 2006 Aug;38(3-4):151-61.
21. Berrougui H, Martin-Cordero C, Khalil A, Hmamouchi M, Ettaib A, Marhuenda E, et al. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. Pharmacol Res. 2006 Aug;54(2):150-7.
22. Abe A, Yamada H. Harmol induces apoptosis by caspase-8 activation independently of Fas/Fas ligand interaction in human lung carcinoma H596 cells. Anticancer Drugs. 2009 Jun;20(5):373-81.
23. Arshad N, Zitterl-Eglseer K, Hasnain S, Hess M. Effect of Peganum harmala or its beta-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry. Phytother Res. 2008 Nov;22(11):1533-8.
24. Chen Q, Chao R, Chen H, Hou X, Yan H, Zhou S, et al. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer. 2005 May 1;114(5):675-82.
25. Ishida J, Wang HK, Bastow KF, Hu CQ, Lee KH. Antitumor agents 201. Cytotoxicity of harmine and betacarboline analogs. Bioorg Med Chem Lett. 1999 Dec 6;9(23):3319-24.
26. Liotta LA. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986 Jan;46(1):1-7.
27. Bergman I, Loxley R. The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta. 1970 Feb;27(2):347-9.
28. Elson LA, Morgan WT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J. 1933;27(6):1824-8.
29. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem. 1962 Oct;4:330-4.
30. Skoza L, Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J. 1976 Dec 1;159(3):457-62.
31. Szasz G. Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem. 1976 Dec;22(12):2051-5.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156-9.
33. Cole SP. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol. 1986;17(3):259-63.
34. Campling BG, Pym J, Baker HM, Cole SP, Lam YM. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer. 1991 Jan;63(1):75-83.
35. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 Jun 15;47(12):3239-45.
36. Lee EJ, Shin I, Kwon SK, Shin HS, Moon A. Chemopreventive allylthiopyridazines inhibit invasion, migration and angiogenesis in hepatocarcinoma cells. Int J Oncol. 2003 Dec;23(6):1645-50.
37. Billings PC, Habres JM, Liao DC, Tuttle SW. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res. 1991 Oct 15;51(20):5539-43.
38. Hill LL, Perussia B, McCue PA, Korngold R. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res. 1994 Feb 1;54(3):763-70.
39. Rouhi P, Lee SL, Cao Z, Hedlund EM, Jensen LD, Cao Y. Pathological angiogenesis facilitates tumor cell dissemination and metastasis. Cell Cycle. 2010 Mar;9(5):913-7.
40. Hamsa TP, Kuttan G. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Eur J Pharmacol. 2010 Dec 15;649(1-3):64-73.
41. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002 Feb 15;277(7):4581-4.
42. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A. Hyaluronan: fundamental principles and applications in cancer. J Intern Med. 1997 Jul;242(1):41-8.
43. Venkatesan N, Punithavathi D, Chandrakasan G. Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats. Biochem Pharmacol. 1998 Oct 1;56(7):895-904.
44. Khadapkar SV, Sheth NA, Bhide SV. Independence of sialic acid levels in normal and malignant growth. Cancer Res. 1975 Jun;35(6):1520-3.
45. Kloppel TM, Keenan TW, Freeman MJ, Morre DJ. Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3011-3.
46. Idiz N, Guvendik G, Bosgelmez, II, Soylemezoglu T, Dogan YB, Ilhan I. Serum sialic acid and gamma-glutamyltransferase levels in alcohol-dependent individuals. Forensic Sci Int. 2004 Dec 2;146 Suppl:S67-70.
47. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985 Jun 14;228(4705):1324-6.
48. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003 Sep 29;22(42):6524-36.
49. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol. 2000 Jul;191(3):245-56.
50. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006 Mar;25(1):9-34.
51. Choi MA, Kim SH, Chung WY, Hwang JK, Park KK. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem Biophys Res Commun. 2005 Jan 7;326(1):210-7.
52. Duffy MJ, Duggan C, Maguire T, Mulcahy K, Elvin P, McDermott E, et al. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein. 1996;49(1-3):85-93.
53. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26;420(6917):860-7.
54. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004 Jul;4(7):540-50.
55. Dong G, Chen Z, Kato T, Van Waes C. The host environment promotes the constitutive activation of nuclear factor-kappaB and pro-inflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res. 1999 Jul 15;59(14):3495-504.
56. Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, et al. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasionand angiogenesis-related molecules. Cancer Sci. 2003 Mar;94(3):244-52.
57. Lazar-Molnar E, Hegyesi H, Toth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 2000 Jun;12(6):547-54.
58. Pignochino Y, Grignani G, Cavalloni G, Motta M, Tapparo M, Bruno S, et al. Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer. 2009;8:118.
59. Hur E, Chang KY, Lee E, Lee SK, Park H. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol Pharmacol. 2001 May;59(5):1216-24.
60. Spallarossa P, Altieri P, Garibaldi S, Ghigliotti G, Barisione C, Manca V, et al. Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res. 2006 Feb 15;69(3):736-45.
61. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res. 2000 Feb;6(2):572-7.
62. Lee SJ, Lim KT. Apoptosis induced by glycoprotein (150-kDa) isolated from Solanum nigrum L. is not related to intracellular reactive oxygen species (ROS) in HCT-116 cells. Cancer Chemother Pharmacol. 2006 Apr;57(4):507-16.
63. Parhar RS, Shi Y, Zou M, Farid NR, Ernst P, al-Sedairy ST. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer. 1995 Jan 17;60(2):204-10.